Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
University of Southern California
University of Southern California
Memgen, Inc.
Trishula Therapeutics, Inc.
Hummingbird Bioscience
Bruckner Oncology
Eli Lilly and Company
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fox Chase Cancer Center
UNICANCER
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Pisa
Western Regional Medical Center
University of Iowa
University of Miami
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
Columbia University
Columbia University
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Columbia University
Washington University School of Medicine
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
University of Southern California
Dartmouth-Hitchcock Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Azaya Therapeutics, Inc.
IRCCS San Raffaele
ARCAGY/ GINECO GROUP
Case Comprehensive Cancer Center
Benaroya Research Institute
University of Ulm
Dana-Farber Cancer Institute